课题基金 / 基金详情

Targeting a Novel Molecular Locus for Pharmacological and Genetic Rescue of Fragile X Syndrome

Targeting a Novel Molecular Locus for Pharmacological and Genetic Rescue of Fragile X Syndrome
针对脆性 X 综合征的药理学和基因拯救的新型分子位点
批准号:
379004
负责人:
Wang Lu-Yang
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-10-01 至 2018-10-01

项目摘要

项目成果

Wang Lu-Yang的其他基金

相似基金

相关文献

中文摘要
翻译
脆性X综合征(FXS)是自闭症谱系障碍(ASD)的一种综合征形式,以多动、癫痫、智能障碍、语言和沟通障碍以及其他自闭症行为为特征。这种综合征是由一种三核苷酸引起的
英文摘要
Fragile X Syndrome (FXS) is a syndromic form of autism spectrum disorder (ASD), characterized by hyperactivity, seizures, intellectual disability, language and communication deficits, and other autistic behaviors. The syndrome is caused by a trinucleotide
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The noncanonical roles of FMRP in gating the pathogenesis and rescue of Fragile X Syndrome
  • 批准号:
    487764
  • 项目类别:
    Operating Grants
  • 资助金额:
    $84.43万
  • 财政年份:
    2023
  • 负责人:
    Wang Lu-Yang
  • 依托单位:
Targeting a Novel Molecular Locus for Pharmacological and Genetic Rescue of Fragile X Syndrome
  • 批准号:
    380070
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.73万
  • 财政年份:
    2018
  • 负责人:
    Wang Lu-Yang
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    404355
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2018
  • 负责人:
    Wang Lu-Yang
  • 依托单位:
The roles of neuronal calcium sensor-1 protein in synaptic development and neuropsychiatric disorders
  • 批准号:
    370143
  • 项目类别:
    Operating Grants
  • 资助金额:
    $74.12万
  • 财政年份:
    2017
  • 负责人:
    Wang Lu-Yang
  • 依托单位:
海外基金